News
Biases in Animal Studies May Differ From Those In Clinical Trials, UCSF Study Finds
A new analysis of animal studies on cholesterol-lowering statins by UC San Francisco researchers found that non-industry studies had results that favored the drugs even more than studies funded by industry. The analysis of 63 animal studies of statins, led by Lisa Bero, PhD, UCSF professor clinical
ExRNA: Decoding Messages Between Cells
RNA has long been known to perform yeoman's duty on the intracellular assembly line, following genetic instructions to help guide protein production. But it turns out that RNA is not merely an essential and reliable, if unexciting, workhorse. Scientists have discovered a type of RNA that ventures
New Mission Bay Family House to Expand Services for Patient Families
For three decades, Family House has offered a supportive home base for families whose children are being treated for cancer and other life-threatening illnesses at UCSF Benioff Children’s Hospital. Now, as the children’s hospital prepares for its move to a new home at Mission Bay, Family House also
UCSF Health Cancer Experts Featured at Premier Cancer Meeting
Oncology specialists from around the globe will gather for the American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest cancer therapies, technologies, research and education. The theme this year is Partnering With Patients: The Cornerstone of Cancer Care and Research. More
Prostate Cancer Study: More Health Benefits from Plant-Based Diet
Men with prostate cancer could significantly reduce the chances of the disease worsening by eating more fruits, vegetables, nuts, and olive oil, according to new research by UC San Francisco. A study of more than 2,000 men with localized prostate cancer found that eating a primarily plant-based diet
Hala Borno, MD, Resident Alum : Ensuring clinical trials serve patients of color
As a war refugee, a Palestinian immigrant, and now an oncologist, Hala Borno knows that access to health care can determine whether a patient survives a life-threatening illness – or not. Cancer outcomes correlate with race and ethnicity partly because clinical drug trials fail to enroll diverse